2m 2m 2m 2m 2m 2m 2m
DERMATA THERAPE (DRMA)
NASDAQ
$0.83-$0.03 (-3.94%)
Price as of Oct 22, 2026 7:57 PM EDT- $4.0MMarket Cap
- -80.55%1-Year Change
- BiotechnologyIndustry
DERMATA THERAPE (DRMA)
$0.83-$0.03 (-3.94%)
DRMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.86 | ||
Change | -$0.07 (-8.09%) | ||
Open | $0.78 | ||
High | $0.87 | ||
Low | $0.78 | ||
Previous Close | $0.80 | ||
Volume | 140,279 | ||
30-Day Average Volume | 7,611,862 | ||
1-Week Change | 20.53% | ||
1-Month Change | -30.48% | ||
1-Year Change | -80.55% | ||
3-Year Change | -99.17% | ||
5-Year Change | -99.99% | ||
Fundamentals | |||
Shares Outstanding | 5.0M | ||
Total Assets | $5.3M | ||
Market Cap | $4.0M | ||
Enterprise Value | -$451,077.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$2.4M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $4.0M | ||
EPS | -$0.74 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 08/01/2025 | ||
Earnings & Revenue